Up 40%, 3%-Yielding Amgen Is Still One Of My Favorite Healthcare Stocks

malerapaso Introduction Last year, I started covering drug manufacturing giant Amgen Inc. (NASDAQ:AMGN). On June 30, I wrote an article titled "Amgen: A Healthcare Bargain With A 4% Yield." Since then, shares are up 41%, beating the 9.5% performance of the S&P 500 (SP500) by a wide margin. This rally restored the company's longer-term performance, as it is now up 240% over the past ten years (including dividends). This beats the strong performances of the S&P 500 and the Health Care Select Sector SPDR Fund ...